{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:08:59Z","timestamp":1747159739564,"version":"3.40.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Local Health Authority of Pisa"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejphar.2015.03.081","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T23:38:37Z","timestamp":1429313917000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment"],"prefix":"10.1016","volume":"760","author":[{"given":"Milo","family":"Meini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Moncini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Daini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Giarratana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Scaramelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Chericoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Stefanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7704-0831","authenticated-orcid":false,"given":"Paola","family":"Rucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.03.081_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1300\/J069v26n01_03","article-title":"Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients","volume":"26","author":"Adelson","year":"2007","journal-title":"J. Addict. Dis."},{"issue":"9","key":"10.1016\/j.ejphar.2015.03.081_bib2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3109\/15563658108990335","article-title":"Specificity of the EMIT drug abuse urine assay methods","volume":"18","author":"Allen","year":"1981","journal-title":"Clin. Toxicol."},{"issue":"6","key":"10.1016\/j.ejphar.2015.03.081_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19 and CYP2C9 genotypes, and response to treatment","volume":"78","author":"Crettol","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1-2","key":"10.1016\/j.ejphar.2015.03.081_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2012.12.010","article-title":"Patient characteristics associated with buprenorphine\/naloxone treatment outcome for prescription opioid dependence: results from a multisite study","volume":"131","author":"Dreifuss","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.ejphar.2015.03.081_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0376-8716(00)00121-6","article-title":"Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment","volume":"61","author":"Eap","year":"2000","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.ejphar.2015.03.081_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004714-200104000-00016","article-title":"Cytocrome P450 2D6 genotype and methadone steady-state concentrations","volume":"21","author":"Eap","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"14","key":"10.1016\/j.ejphar.2015.03.081_bib7","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.ejphar.2015.03.081_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002280050128","article-title":"Replacement of (R)-methadone by double dose of (R,S)-methadone in addicts: interindividual variability of the (R)\/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics","volume":"50","author":"Eap","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2015.03.081_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10550880903183042","article-title":"High dose versus moderate dose methadone maintenance: is there a better outcome?","volume":"28","author":"Fareed","year":"2009","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.ejphar.2015.03.081_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone-metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2015.03.081_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03256370","article-title":"Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes","volume":"14","author":"Fonseca","year":"2010","journal-title":"Mol. Diagn. Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2015.03.081_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.drugalcdep.2005.06.005","article-title":"Therapeutic thresholds in methadone maintenance treatment: a receiver operating characteristic analysis","volume":"81","author":"Hallinan","year":"2006","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.ejphar.2015.03.081_bib13","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00228-009-0706-8","article-title":"Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study","volume":"65","author":"Hallinan","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.03.081_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002130050963","article-title":"Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment","volume":"143","author":"Hiltunen","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2015.03.081_bib15","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistant gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"s1","key":"10.1016\/j.ejphar.2015.03.081_bib16","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1526-4637.2009.00596.x","article-title":"Opioid metabolism and effects of cytochrome P450","volume":"10","author":"Holmquist","year":"2009","journal-title":"Pain Med."},{"issue":"11","key":"10.1016\/j.ejphar.2015.03.081_bib17","article-title":"Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan","volume":"7","author":"Lee","year":"2012","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.ejphar.2015.03.081_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03256276","article-title":"Interindividual variability of methadone response: impact of genetic polymorphisms","volume":"12","author":"Li","year":"2008","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.ejphar.2015.03.081_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0376-8716(92)90058-K","article-title":"The use of plasma levels to optimize methadone maintenance treatment","volume":"30","author":"Loimer","year":"1992","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2015.03.081_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1521-0391.2009.00009.x","article-title":"Effect of cocaine use on methadone pharmacokinetics in humans","volume":"19","author":"McCance-Katz","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.ejphar.2015.03.081_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2009","journal-title":"Am. J. Addict."},{"issue":"4","key":"10.1016\/j.ejphar.2015.03.081_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1360-0443.2011.03374.x","article-title":"(R)-methadone versus racemic methadone: what is best for patient care?","volume":"106","author":"McCance-Katz","year":"2011","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.ejphar.2015.03.081_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2004.02221.x","article-title":"Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone esposure","volume":"58","author":"Mitchell","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2015.03.081_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2125.2008.03312.x","article-title":"Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment","volume":"67","author":"Shiran","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2015.03.081_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","article-title":"Actual and Potential Drug Interactions Associated with Methadone","volume":"9","author":"Weschules","year":"2008","journal-title":"Pain Med."},{"key":"10.1016\/j.ejphar.2015.03.081_bib26","unstructured":"World Health Organization, 2009. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. \u3008http:\/\/www.who.int\/substance_abuse\/publications\/opioid_dependence_guidelines.pdf\u3009"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915003234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915003234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:54:25Z","timestamp":1537689265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915003234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":26,"alternative-id":["S0014299915003234"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.081","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}